Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
08 April 2019 | Story Valentino Ndaba | Photo Valentino Ndaba
Andrew Lane
Mining the fourth industrial revolution way is the future says industry expert, Andrew Lane.

Innovation is imperative for the future of mining in South Africa. Industry expert, Andrew Lane proposes that leveraging on new information, mining technologies and energy knowhow, which are the hallmarks of the fourth industrial revolution, should set the scene for success.

Lane who is Africa Energy and Resource Leader at Deloitte, engaged students at a recent guest lecture hosted by the University of the Free State’s Business School on the Bloemfontein Campus. “The future is intelligent mining. It’s not just about technology; it’s about changing the way you do business,” he said.

Transforming traditional to trailblazing
“What gives you sustainable competitive advantage is the rate at which you innovate,” said Lane. Design paradigm shifts in the South African mining industry may have resulted in about 100 000 job losses during the past four years. However, mining companies stand to achieve significant gains through applying innovation.

Despite most of South Africa’s mines nearing the end of their lives, mining remains a large employer and investor attractor which ensures that the country holds a competitive advantage in the global economy. Lane is adamant that, “even though we have declined from 20% to 5% in terms of GDP contributions, mining remains a large contributor to export earnings”.

Reaching resource-rich regions
While some physical resources are inaccessible using current technology, “new mineral-processing technologies help tap into previously uneconomical mineral deposits”, according to Lane. In addition to the environment, 3D visualisation cameras can track employees and equipment in the bowels of the earth.

More mining, less loss
Integrating mining, energy, and information technology will ensure that companies reduce people, capital and energy intensity, while increasing mining intensity. The impossible can be achieved if technology is used well for developmental outcomes, employment, and improving standards of living.



News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept